Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tremblay

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Plos Genetics|February 9, 2022
Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndromeMichel G Tremblay, Dany S Sibai, Melissa Valère, et al.
Developmental Biology|April 25, 2006
Role of Sox2 in the development of the mouse neocortexMahmud Bani-Yaghoub, Roger G Tremblay, Joy X Lei, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcomeM Maziade, S Bouchard, N Gingras, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onsetM Maziade, N Gingras, C Rodrigue, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.
Gene Therapy|June 22, 2012
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trialD Gaudet, J Méthot, S Déry, et al.
JMIR Research Protocols|December 12, 2022
Virtual Reality-Augmented Physiotherapy for Chronic Pain in Youth: Protocol for a Randomized Controlled Trial Enhanced With a Single-Case Experimental DesignLaura E Simons, Courtney W Hess, Ellison S Choate, et al.
Clinical Genetics|July 1, 1997
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of QuebecM C Vohl, S Moorjani, M Roy, et al.
Brain Stimulation|August 22, 2024
Thalamic transcranial ultrasound stimulation in treatment resistant depressionJoline M Fan, Kai Woodworth, Keith R Murphy, et al.
Molecular Cell|September 16, 2022
Control of ribosomal RNA synthesis by hematopoietic transcription factorsCharles Antony, Subin S George, Justin Blum, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Plos Genetics|February 9, 2022
Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndromeMichel G Tremblay, Dany S Sibai, Melissa Valère, et al.
Developmental Biology|April 25, 2006
Role of Sox2 in the development of the mouse neocortexMahmud Bani-Yaghoub, Roger G Tremblay, Joy X Lei, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcomeM Maziade, S Bouchard, N Gingras, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onsetM Maziade, N Gingras, C Rodrigue, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.
Gene Therapy|June 22, 2012
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trialD Gaudet, J Méthot, S Déry, et al.
JMIR Research Protocols|December 12, 2022
Virtual Reality-Augmented Physiotherapy for Chronic Pain in Youth: Protocol for a Randomized Controlled Trial Enhanced With a Single-Case Experimental DesignLaura E Simons, Courtney W Hess, Ellison S Choate, et al.
Clinical Genetics|July 1, 1997
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of QuebecM C Vohl, S Moorjani, M Roy, et al.
Brain Stimulation|August 22, 2024
Thalamic transcranial ultrasound stimulation in treatment resistant depressionJoline M Fan, Kai Woodworth, Keith R Murphy, et al.
Molecular Cell|September 16, 2022
Control of ribosomal RNA synthesis by hematopoietic transcription factorsCharles Antony, Subin S George, Justin Blum, et al.
Pageof 17